glp 1 agonist gastric emptying Clinical Consequences of Delayed With GLP-1 Receptor Agonists and Tirzepatide GLP-1 Agonist Delayed Gastric Emptying:

In conclusion, GLP-1RAs exhibit substantial anti-inflammatory effects, rendering them promising therapeutic agents with broad clinical implications

Afshin A., Forouzanfar M.H., Reitsma M.B., Sur P., Estep K., Lee A., Marczak L., Mokdad A.H., Moradi-Lakeh M., et al

Biochim Biophys Acta 1830:34073413

In: Abstract conference: 70th scientific sessions of the American Diabetes Association

(26) GLP-1 agonists also demonstrated consistent reductions in lower limb amputation risk across subgroups, including those with peripheral arterial disease (PAD) and patients on antihypertensive therapy

Cohort entry was defined as the date of the first-ever prescription for one of the drugs of interest (GLP-1RAs, SGLT2 inhibitors, metformin or other second- or third-line glucose-lowering drugs) during the study period, and their respective first exposure was defined as the index event